These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 424946)

  • 1. Oxprenolol plus cyclopenthiazide-KCl versus methyldopa in the treatment of hypertension.
    Seedat YK
    S Afr Med J; 1979 Jan; 55(4):114. PubMed ID: 424946
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
    Levenstein JH
    S Afr Med J; 1978 Nov; 54(21):860-4. PubMed ID: 371021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice.
    Elsdon-Dew RW; Holden E
    J Int Med Res; 1981; 9(5):315-8. PubMed ID: 7028531
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxprenolol slow-release with cyclopenthiazide KCl in the treatment of essential hypertension. A multicentre general practice study.
    Levenstein JH
    S Afr Med J; 1981 Jun; 59(25):893-9. PubMed ID: 7015537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trasidrex (a fixed combination of slow Trasicor 16o mg and Navidrex 0.25mg) in the treatment of hypertension: a multicentre clinical trial in general practice.
    Ebbut AF; Elsdon-Dew RW; Murphy JE
    J Int Med Res; 1978; 6(6):494-8. PubMed ID: 720740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuretics, beta blockers and vasodilators. Dosage in mild and moderate hypertension.
    Goble AJ
    Med J Aust; 1975 Jan; 1(SP2):14-7. PubMed ID: 1124020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
    Gyntelberg F; Jacobsen K; Martlev A; Backer P
    Ugeskr Laeger; 1977 Mar; 139(11):641-6. PubMed ID: 320734
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: General practitioner studies of beta-blockade in hypertension.
    Forrest WA
    Scott Med J; 1974 Jan; 19(1):49-50. PubMed ID: 4150628
    [No Abstract]   [Full Text] [Related]  

  • 9. A multicentre study examining the substitution of Trasidrex for the free combination of Slow-Trasicor and Navidrex-K.
    Ebbutt AF; Elsdon-Dew RW
    J Int Med Res; 1979; 7(6):524-7. PubMed ID: 520655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open comparison between free and a fixed combination of diuretic and beta-blocker in the management of essential hypertension.
    Forrest WA
    J Int Med Res; 1980; 8(2):127-31. PubMed ID: 6102939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral diuretics and hypertension.
    Waal-Manning HJ
    N Z Med J; 1982 Apr; 95(706):287-8. PubMed ID: 6953383
    [No Abstract]   [Full Text] [Related]  

  • 12. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
    Forrest WA; Bridgman KM; Ebbutt AF
    Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteins.
    Ballantyne D; Ballantyne FC; McMurdo
    Atherosclerosis; 1981 Jun; 39(3):301-6. PubMed ID: 7259814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxprenolol and a thiazide diuretic together in the treatment of essential hypertension--a large general practice study.
    Forrest WA
    Br J Clin Pract; 1973 Sep; 27(9):331-5. PubMed ID: 4595072
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxprenolol plus cyclopenthiazide-kci versus methyldopa in the treatment of hypertension.
    Levenstein JH
    S Afr Med J; 1979 Apr; 55(17):656. PubMed ID: 462285
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension.
    Wray R; Benton KG; Whitehill D; Wright B; Weener W; Whittington JR
    Curr Med Res Opin; 1983; 8(9):665-74. PubMed ID: 6365467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a sustained-release formulation of oxprenolol and cyclopenthiazide ('Trasidrex') in the management of hypertension: a general practice study.
    Forrest WA
    Curr Med Res Opin; 1980; 6(8):559-63. PubMed ID: 7389387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prazosin combined with thiazide diuretic and beta-blocker in the treatment of hypertension.
    Seedat YK; Seedat MA; Bhoola R
    Curr Med Res Opin; 1977; 4(9):627-9. PubMed ID: 590023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium supplements.
    Waal-Manning HJ
    N Z Med J; 1982 May; 95(707):326. PubMed ID: 6954394
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study.
    Crisp AJ; Kennedy PG; Hoffbrand BI; Ebbutt AF; Carruthers M
    Curr Med Res Opin; 1980; 7(2):101-3. PubMed ID: 7002477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.